Nevertheless, the breast cancer patient gene expression microarray and methylated DNA immunoprecipitation analyses clearly show that BRCA1 mutation is significantly associated with FOXA1 gene promoter methylation and expression downregulation. The gene discussed is FOXA1; the disease is breast carcinoma.